New research published in JAMA Network shows that nationwide naloxone prescriptions declined at the start of the pandemic and have yet to reach pre-pandemic levels.

FDA reminded health care professionals and the public that results from currently authorized COVID-19 antibody tests should not be used to assess a person’s level of immunity or protection from COVID-19 at any time, particularly after the person has received a COVID-19 vaccination.

Venous thromboembolism (VTE) is the most commonly reported thrombotic complication of COVID-19, with approximately 28% of critically ill patients with COVID-19 experiencing VTE. However, limited data are available to guide the intensity of antithrombotic prophylaxis.

Researchers from the University of Michigan examined vaccination against human papillomavirus (HPV) in young adults versus adolescents for an 8-year period, from 2010 to 2018. Regardless of what age they were at first dose, more survey respondents opted for vaccination as the years passed. Still, compared with adolescents—68% of whom received one or more HPV doses by 2018—overall takeup among young adults was low.

The Institute for Safe Medication Practices (ISMP) continues to track the errors that have been reported from the currently authorized COVID-19 vaccines.